These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30338233)

  • 21. Serum Apelin: A New Marker of Early Atherosclerosis in Children with Type 1 Diabetes Mellitus.
    Sabry RN; El Wakeel MA; El-Kassas GM; Amer AF; El Batal WH; El-Zayat SR; Abou-El-Asrar M
    Open Access Maced J Med Sci; 2018 Apr; 6(4):613-617. PubMed ID: 29731925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of different antidiabetic drugs based on metformin in the treatment of type 2 diabetes mellitus: A network meta-analysis involving eight eligible randomized-controlled trials.
    Peng Y; Chen SH; Liu XN; Sun QY
    J Cell Physiol; 2019 Mar; 234(3):2795-2806. PubMed ID: 30145806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial effects of a glyburide/metformin combination preparation in type 2 diabetes mellitus.
    Bokhari SU; Gopal UM; Duckworth WC
    Am J Med Sci; 2003 Feb; 325(2):66-9. PubMed ID: 12589230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of exercise training on adipose tissue apelin expression in streptozotocin-nicotinamide induced diabetic rats.
    Kazemi F; Zahediasl S
    Gene; 2018 Jul; 662():97-102. PubMed ID: 29626513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal function markers and metformin eligibility.
    Tavares Bello C; Castro Fonseca R; Sousa Santos F; Sequeira Duarte J; Azinheira J; Vasconcelos C
    Minerva Endocrinol; 2018 Sep; 43(3):246-252. PubMed ID: 28565889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactive effects of apelin, renin-angiotensin system and nitric oxide in treatment of obesity-induced type 2 diabetes mellitus in male albino rats.
    Sabry MM; Mahmoud MM; Shoukry HS; Rashed L; Kamar SS; Ahmed MM
    Arch Physiol Biochem; 2019 Jul; 125(3):244-254. PubMed ID: 29564917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes.
    Garber AJ; Larsen J; Schneider SH; Piper BA; Henry D;
    Diabetes Obes Metab; 2002 May; 4(3):201-8. PubMed ID: 12047399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up.
    Fisman EZ; Tenenbaum A; Boyko V; Benderly M; Adler Y; Friedensohn A; Kohanovski M; Rotzak R; Schneider H; Behar S; Motro M
    Clin Cardiol; 2001 Feb; 24(2):151-8. PubMed ID: 11460818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-talk between apelin and vasopressin in response to different osmotic stimuli in type 2 diabetic rats.
    Dawood AF; Sabry MM; Estaphan SA; Mohamed EA; Younes SF; Rashed LA; Elzainy AW
    J Biol Regul Homeost Agents; 2018; 32(5):1117-1127. PubMed ID: 30334404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perinatal impact of the use of metformin and glyburide for the treatment of gestational diabetes mellitus.
    Silva JC; Fachin DR; Coral ML; Bertini AM
    J Perinat Med; 2012 Jan; 40(3):225-8. PubMed ID: 22505499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study.
    Nachum Z; Zafran N; Salim R; Hissin N; Hasanein J; Gam Ze Letova Y; Suleiman A; Yefet E
    Diabetes Care; 2017 Mar; 40(3):332-337. PubMed ID: 28077460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.
    Viberti G; Kahn SE; Greene DA; Herman WH; Zinman B; Holman RR; Haffner SM; Levy D; Lachin JM; Berry RA; Heise MA; Jones NP; Freed MI
    Diabetes Care; 2002 Oct; 25(10):1737-43. PubMed ID: 12351470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation between plasma Apelin level and peripheral neuropathy in Type 2 diabetic patients.
    Hosny SS; Nasr MS; Ibrahim RH; YousryHelal Z
    Diabetes Metab Syndr; 2019; 13(1):626-629. PubMed ID: 30641779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin in combination with rosiglitazone contribute to the increased serum adiponectin levels in people with type 2 diabetes mellitus.
    Nie JM; Li HF
    Exp Ther Med; 2017 Sep; 14(3):2521-2526. PubMed ID: 28962190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes.
    Zinman B; Haffner SM; Herman WH; Holman RR; Lachin JM; Kravitz BG; Paul G; Jones NP; Aftring RP; Viberti G; Kahn SE;
    J Clin Endocrinol Metab; 2010 Jan; 95(1):134-42. PubMed ID: 19875477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin.
    Al-Kuraishy HM; Al-Gareeb AI; Alblihed M; Cruz-Martins N; Batiha GE
    Front Med (Lausanne); 2021; 8():644295. PubMed ID: 33718411
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.
    Hermann LS; Scherstén B; Bitzén PO; Kjellström T; Lindgärde F; Melander A
    Diabetes Care; 1994 Oct; 17(10):1100-9. PubMed ID: 7821128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of glyburide with metformin in treating gestational diabetes mellitus: a systematic review and meta-analysis.
    Amin M; Suksomboon N; Poolsup N; Malik O
    Clin Drug Investig; 2015 Jun; 35(6):343-51. PubMed ID: 25985837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
    Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apelin: A potential novel serum biomarker for early detection of diabetic nephropathy in patients with type 2 diabetes.
    Demirpence M; Yilmaz H; Colak A; Pamuk BO; Karakoyun I; Basok B
    North Clin Istanb; 2019; 6(2):151-155. PubMed ID: 31297482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.